Spotlight on MXC - time to re evaluate, page-3

I would be more inclined to say "when" - this will gain momentum so its a nexericse in patience as the company making all the right noises IMO

Most people are too impatient and the big gains will be made in 2017 IMO
iTS GOING TO BE A GREAT YEAR for MXC that im certain-
And once they generate those larger contracts and get the green light in Australia - we will control this market as we way advanced - if people like the story unfolding then its decision time - buy now or wait until some of these things come into fruition then buy, as they are already starting to unfold if people actually read the announcements as the clues are there for everyone to see

Also dont forget this event coming up soon !!

Startup Daily article re: Seedlings event
http://www.startupdaily.net/2016/10/medicina
dont forget - industry stakeholders will be sniffing around


What should also be noted is Seedlings is being held on October 29, the day before medicinal cannabis will be recategorised to a Schedule 8 substance, officially making it available to specific patient groups.
Currently in NSW any cannabis possession is considered as a criminal offence and is considered a Schedule 9 drug, placing it in the same category as drugs like heroin. This factor alone makes cannabis and its use for medicinal purposes illegal, however federal legislation is set to change on October 30 to enable the domestic cultivation and manufacture of cannabis for medicinal and related research purposes.- what will this do to our shareprice
Since Victoria became the first Australian state to legalise the manufacture and supply of cannabis for scientific and medicinal purposes, cultivators and startups have begun the lengthy process of securing an Australian license. Along with BuddingTech, based at Sydney’s Fishburners, regional Victorian startup LeafCann was one of the first ever startups to seek a cultivator’s license.